
Rapid exome service
XOME Express (Trio)
Genetic exome sequencing for fast identification of top variants using BGI's automated variant analysis pipeline.
XOME gives clinicians, hospitals, geneticists, and families a clear pathway into targeted panels, exome sequencing, whole genome testing, and validation workflows with clinically structured reporting and practical turnaround times.

Our tests
From focused validation services to whole exome and clinical whole genome testing, XOME supports multiple entry points depending on phenotype clarity, family history, turnaround needs, and diagnostic complexity.
Broad-coverage sequencing for rare disease and complex cases.
Targeted gene testing for suspected monogenic conditions.
Add-on confirmation for variants and copy-number changes.
Featured pathways

Rapid exome service
Genetic exome sequencing for fast identification of top variants using BGI's automated variant analysis pipeline.

Comprehensive exome
Whole exome sequencing across 180,000+ exons and 22,000 genes for rare genetic disorders and unclear clinical genotypes.

Focused monogenic panel
Targeted sequencing for monogenic disease assessment with clinically directed scope for patients or families with a strong suspected diagnosis.

Expanded monogenic panel
Targeted sequencing of over 5,000 disease types across 10 body systems in conjunction with clinical presentation and disease progression markers.
Technology coverage
The XOME portfolio spans targeted panels, exome, and whole genome strategies with clinically relevant variant classes and family-based interpretation options where needed.
SNV and InDel detection
Exon-level and chromosome-level CNV
Mitochondrial genome analysis
Deep intron review where applicable
Structural variation and loss of heterozygosity
Dynamic mutation support in selected workflows
Clinical workflow
The website is built for clinicians and institutions that need clarity fast, while still being understandable for patients and families reviewing their options.
A trusted collaboration



Why this partnership
XOME is presented as a clinical partnership rather than a generic brochure, making the collaboration visible in the first viewport and reinforcing trust throughout the site.
Co-branded delivery model combining Geneticlab's local clinical access with BGI's sequencing infrastructure
Testing options spanning targeted panels, validation services, exome, and whole genome
Trio workflows available where family-based interpretation improves clinical clarity
Turnaround-conscious packages for time-sensitive institutions and high-throughput settings
Speak with the team
Call geneticlab directly for service access, logistics, and next-step guidance.